Sponsor list ยท NAICS 3254
H-1B sponsors: pharmaceutical manufacturers
622 employers filed 4,983 certified H-1B LCAs (NAICS 3254) from Jul 2025 to Jun 2026. The 100 with the most filings:
| Employer | Certified LCAs | Median salary | Latest decision | |
|---|---|---|---|---|
| 1 | Eli Lilly and Company | 417 | $141,000 | Jun 2026 |
| 2 | Bristol-Myers Squibb Company | 219 | $155,876 | Jun 2026 |
| 3 | AbbVie Inc. | 210 | $152,125 | Jun 2026 |
| 4 | Takeda Development Center Americas, Inc. | 131 | $148,000 | Jun 2026 |
| 5 | AstraZeneca Pharmaceuticals LP | 120 | $157,517 | Jun 2026 |
| 6 | Laboratory Corporation of America Holdings | 106 | $112,798 | Jun 2026 |
| 7 | St. Jude Medical, Cardiology Division, Inc. | 105 | $115,000 | Jun 2026 |
| 8 | Abbott Laboratories | 87 | $135,000 | Jun 2026 |
| 9 | Sanofi US Services Inc. | 70 | $128,773 | Jun 2026 |
| 10 | GlaxoSmithKline LLC | 68 | $132,842 | Jun 2026 |
| 11 | IQVIA RDS Inc. | 62 | $147,708 | Jun 2026 |
| 12 | Biogen Inc. | 56 | $137,342 | Jun 2026 |
| 13 | Zoetis, Inc. | 56 | $119,134 | Jun 2026 |
| 14 | InvaGen Pharmaceuticals, Inc. | 52 | $85,000 | Jun 2026 |
| 15 | Pfizer Inc. | 52 | $128,221 | Jun 2026 |
| 16 | Granules Pharmaceuticals Inc. | 48 | $84,500 | Jun 2026 |
| 17 | Alcon Research, LLC | 42 | $107,141 | Jun 2026 |
| 18 | Alexion Pharmaceuticals, Inc. | 41 | $145,000 | Jun 2026 |
| 19 | Celltrion Branchburg, LLC | 40 | $119,445 | Jun 2026 |
| 20 | Bayer U.S. LLC | 39 | $162,000 | Jun 2026 |
| 21 | Incyte Corporation | 39 | $150,000 | Jun 2026 |
| 22 | Sanofi Pasteur Inc. | 39 | $113,464 | Jun 2026 |
| 23 | AbbVie Bioresearch Center Inc. | 38 | $134,000 | Jun 2026 |
| 24 | Boehringer Ingelheim Pharmaceuticals, Inc. | 37 | $145,800 | Jun 2026 |
| 25 | Insulet Corporation | 37 | $155,000 | Jun 2026 |
| 26 | Amneal Pharmaceuticals, LLC | 36 | $110,634 | Jun 2026 |
| 27 | Sciegen Pharmaceuticals INC. | 36 | $82,961 | Jun 2026 |
| 28 | Takeda Pharmaceuticals USA, Inc. | 36 | $188,879 | May 2026 |
| 29 | Abbott Diabetes Care, Inc. | 35 | $139,000 | Jun 2026 |
| 30 | Alnylam US, Inc. | 35 | $165,000 | Jun 2026 |
| 31 | Exelixis, Inc | 34 | $209,542 | Jun 2026 |
| 32 | Lonza Houston INC | 34 | $113,658 | Jun 2026 |
| 33 | Curia Global, Inc. | 32 | $100,050 | Jun 2026 |
| 34 | Alkermes, Inc. | 31 | $141,556 | Jun 2026 |
| 35 | CSL Behring L.L.C. | 31 | $140,369 | Jun 2026 |
| 36 | AbbVie US LLC | 30 | $151,268 | May 2026 |
| 37 | Hologic, Inc. | 30 | $140,168 | Jun 2026 |
| 38 | Revolution Medicines, INC. | 30 | $179,750 | Jun 2026 |
| 39 | Bayer HealthCare LLC | 29 | $142,830 | Jun 2026 |
| 40 | Legend Biotech USA, Inc. | 29 | $115,000 | Jun 2026 |
| 41 | Daiichi Sankyo, INC. | 28 | $162,392 | Jun 2026 |
| 42 | Tris Pharma, Inc. | 28 | $97,739 | Jun 2026 |
| 43 | Herbalife International of America, Inc. | 27 | $160,421 | Jun 2026 |
| 44 | Novo Nordisk, Inc. | 27 | $167,000 | Jun 2026 |
| 45 | Novo Nordisk Research & Development US, Inc. | 27 | $135,000 | Jun 2026 |
| 46 | Amneal Pharmaceuticals Of NY LLC | 26 | $112,000 | Jun 2026 |
| 47 | Sarepta Therapeutics, Inc. | 25 | $120,000 | May 2026 |
| 48 | Hikma Pharmaceuticals USA Inc. | 23 | $103,126 | Jun 2026 |
| 49 | Alcon Vision, LLC | 22 | $121,636 | Jun 2026 |
| 50 | Havix Group Inc. | 22 | $62,500 | Jun 2026 |
| 51 | Roche Molecular Systems, Inc. | 21 | $146,400 | Jun 2026 |
| 52 | Cambrex Charles City, Inc. | 20 | $94,001 | Jun 2026 |
| 53 | Fortrea Inc. | 20 | $125,694 | Jun 2026 |
| 54 | Jazz Pharmaceuticals, Inc. | 20 | $165,448 | Jun 2026 |
| 55 | Laboratory Corporation of America | 20 | $80,652 | Jun 2026 |
| 56 | Lonza Biologics Inc. | 20 | $112,142 | Apr 2026 |
| 57 | Tailstorm Health, Inc | 19 | $92,352 | Jun 2026 |
| 58 | AbbVie Biotherapeutics Inc. | 18 | $151,080 | Jun 2026 |
| 59 | Eisai Inc. | 18 | $190,000 | Jun 2026 |
| 60 | Riconpharma, LLC | 18 | $98,732 | Jun 2026 |
| 61 | Siemens Healthcare Diagnostics, Inc. | 18 | $137,446 | Jun 2026 |
| 62 | Kashiv BioSciences LLC | 17 | $95,000 | Jun 2026 |
| 63 | Ascent Pharmaceuticals, INC. | 16 | $81,978 | May 2026 |
| 64 | Catalent Indiana, LLC | 16 | $95,634 | Jun 2026 |
| 65 | Nivagen Pharmaceuticals, Inc. | 16 | $92,250 | Jun 2026 |
| 66 | Mylan Inc. | 15 | $113,568 | Jun 2026 |
| 67 | Actavis Laboratories FL, Inc. | 14 | $138,553 | May 2026 |
| 68 | Corixa Corporation | 14 | $96,933 | Jun 2026 |
| 69 | Guardian Drug Company, Inc. | 14 | $87,220 | Jun 2026 |
| 70 | Strides Pharma Inc. | 14 | $84,494 | Jun 2026 |
| 71 | Nevro Corp | 13 | $142,526 | May 2026 |
| 72 | Novel Laboratories, Inc. | 13 | $96,660 | Jun 2026 |
| 73 | Novitium Pharma LLC | 13 | $99,528 | Jun 2026 |
| 74 | Otsuka Pharmaceutical Development & Commercialization, Inc. | 13 | $175,000 | Jun 2026 |
| 75 | Aveva Drug Delivery Systems, Inc. | 12 | $87,500 | Jun 2026 |
| 76 | Boehringer Ingelheim Animal Health USA, INC. | 12 | $143,252 | Jun 2026 |
| 77 | Evaric Pharmaceuticals INC. | 12 | $86,250 | May 2026 |
| 78 | Rising Pharma Holdings Inc. | 12 | $139,400 | Jun 2026 |
| 79 | Shree Meldi Krupa LLC | 12 | $66,934 | Jun 2026 |
| 80 | St. Jude Medical S.C. Inc. | 12 | $88,350 | May 2026 |
| 81 | United Therapeutics Corporation | 12 | $123,848 | Jun 2026 |
| 82 | Advanced Accelerator Applications USA, Inc. | 11 | $100,901 | May 2026 |
| 83 | Bayer HealthCare Pharmaceuticals Inc. | 11 | $170,000 | Jun 2026 |
| 84 | Belcher Pharmaceuticals, LLC | 11 | $83,574 | May 2026 |
| 85 | Berkshire Sterile Manufacturing, LLC | 11 | $96,822 | May 2026 |
| 86 | BioMarin Pharmaceutical Inc. | 11 | $164,798 | Dec 2025 |
| 87 | St. Jude Medical Business Services, Inc. | 11 | $120,000 | Jun 2026 |
| 88 | Teva Pharmaceuticals USA, Inc. | 11 | $138,105 | Apr 2026 |
| 89 | Abbott Diabetes Care Sales Corporation | 10 | $142,500 | May 2026 |
| 90 | BACTOLAC PHARMACEUTICAL, Inc. | 10 | $90,000 | Jun 2026 |
| 91 | BeOne Medicines US Manufacturing Co., Inc. | 10 | $150,949 | Jun 2026 |
| 92 | Brio Pharmaceuticals Inc | 10 | $74,672 | Jun 2026 |
| 93 | CooperSurgical, Inc. | 10 | $97,891 | Jun 2026 |
| 94 | Labcorp Early Development Laboratories Inc. | 10 | $75,380 | Apr 2026 |
| 95 | Novo Nordisk Pharmaceutical Industries, LP | 10 | $128,637 | May 2026 |
| 96 | Sannova Analytical LLC | 10 | $83,000 | Jun 2026 |
| 97 | Shire Human Genetic Therapies Inc. | 10 | $123,097 | Jun 2026 |
| 98 | Abbott Cardiovascular Systems Inc. | 9 | $100,000 | Jun 2026 |
| 99 | Adare Pharmaceuticals Inc. | 9 | $100,000 | Mar 2026 |
| 100 | Agios Pharmaceuticals, Inc. | 9 | $160,000 | Apr 2026 |
"Cap-exempt": files mostly as a college or university, so its hires skip the H-1B lottery. A filing in this list means the employer submitted a certified LCA in the period; it is not a promise to sponsor anyone. Industry codes are self-reported on the filing.